Literature DB >> 15064755

Molecular recognition of BMP-2 and BMP receptor IA.

Sascha Keller1, Joachim Nickel, Jin-Li Zhang, Walter Sebald, Thomas D Mueller.   

Abstract

Bone morphogenetic protein-2 (BMP-2) and other members of the TGF-beta superfamily regulate the development, maintenance and regeneration of tissues and organs. Binding epitopes for these extracellular signaling proteins have been defined, but hot spots specifying binding affinity and specificity have so far not been identified. In this study, mutational and structural analyses show that epitopes of BMP-2 and the BRIA receptor form a new type of protein-protein interface. The main chain atoms of Leu 51 and Asp53 of BMP-2 represent a hot spot of binding to BRIA. The BMP-2 variant L51P was deficient in type I receptor binding only, whereas its overall structure and its binding to type II receptors and modulator proteins, such as noggin, were unchanged. Thus, the L51P substitution converts BMP-2 into a receptor-inactive inhibitor of noggin. These results are relevant for other proteins of the TGF-beta superfamily and provide useful clues for structure-based drug design.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064755     DOI: 10.1038/nsmb756

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  76 in total

1.  Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes.

Authors:  Jing-Jie Li; Satoshi Sugimura; Thomas D Mueller; Melissa A White; Georgia A Martin; Lesley J Ritter; Xiao-Yan Liang; Robert B Gilchrist; David G Mottershead
Journal:  Mol Endocrinol       Date:  2015-01

2.  Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression.

Authors:  Mahta Nili; Ujwal Shinde; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

3.  Crystallization of BMP receptor type IA bound to the antibody Fab fragment AbD1556.

Authors:  Stefan Harth; Alexander Kotzsch; Walter Sebald; Thomas Dieter Mueller
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-29

4.  Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly.

Authors:  Michael J Isaacs; Yasuhiko Kawakami; George P Allendorph; Byung-Hak Yoon; Juan Carlos Izpisua Belmonte; Senyon Choe
Journal:  Mol Endocrinol       Date:  2010-05-19

5.  Covalent binding of BMP-2 on surfaces using a self-assembled monolayer approach.

Authors:  Theresa L M Pohl; Elisabeth H Schwab; Elisabetta A Cavalcanti-Adam
Journal:  J Vis Exp       Date:  2013-08-26       Impact factor: 1.355

6.  Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.

Authors:  Jennifer N Cash; Elizabeth B Angerman; Henry T Keutmann; Thomas B Thompson
Journal:  Mol Endocrinol       Date:  2012-05-16

7.  N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.

Authors:  Jonathan W Lowery; Jose M Amich; Alex Andonian; Vicki Rosen
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

Review 8.  Structural Biology and Evolution of the TGF-β Family.

Authors:  Andrew P Hinck; Thomas D Mueller; Timothy A Springer
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

9.  Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism.

Authors:  Kristof Nolan; Chandramohan Kattamuri; Scott A Rankin; Randy J Read; Aaron M Zorn; Thomas B Thompson
Journal:  Cell Rep       Date:  2016-08-11       Impact factor: 9.423

Review 10.  Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.

Authors:  Catherine Baugé; Nicolas Girard; Eva Lhuissier; Celine Bazille; Karim Boumediene
Journal:  Aging Dis       Date:  2013-12-17       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.